Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0000950170-24-025189

EVP & Chief Commercial Officer sold 26,949 shares at an average $1.18 ($31,684)

From the SEC's structured data for this filing

Trades in this filing

Cheng Sohanya Roshan · EVP & Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-29 Sale : show line 1 in the form −21,840 $1.17 $25,553 398,618 D
2024-03-01 Sale : show line 2 in the form −5,109 $1.20 $6,131 393,509 D
Open-market sales · 26,949 sh · avg $1.18 · $31,684
Loading xslF345X05/ownership.xml…